Mtg (7806) · InitiativeAdvanced
Expanding the healthcare and pharmaceutical business base through M&A
First written in FY2018-Q3. 1 of 2 entries say "Advanced", first in FY2018. Latest entry: FY2018.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Expansion of the Medical Device and Pharmaceutical Business Platform Through the Acquisition of MTGメディカル as a SubsidiaryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2018AdvancedAnnual report
「From the current consolidated fiscal year, MTGメディカル, of which we acquired 100% of the issued shares, has been included in the scope of consolidation.」
Included MTGメディカル, acquired in full in 2017, in the scope of consolidation and incorporated into the Group the business base of a subsidiary holding licences for medical devices and pharmaceuticals. - FY2018-Q3First statedAnnual report
「In November 2017, we conducted M&A and acquired 100% of the shares of ミチノ製薬株式会社 (currently MTGメディカル). This subsidiary holds licences for Type 2 medical device manufacturing and marketing and Type 2 pharmaceutical manufacturing and marketing, and is expected to contribute to the future development of the Group’s businesses.」
Seeking to expand the business base from the existing Beauty and Wellness fields into medical devices and pharmaceuticals by leveraging the licences held by the wholly owned subsidiary.